Literature DB >> 10792285

Flow cytometric and functional characterization of AC133+ cells from human umbilical cord blood.

M Pasino1, T Lanza, F Marotta, L Scarso, P De Biasio, S Amato, A Corcione, V Pistoia, P G Mori.   

Abstract

AC133+ cells may represent an alternative source of transplantable haemopoietic progenitor cells to CD34+ cells. Here, we have addressed the characterization of umbilical cord blood (UCB) AC133+ cells and compared their immunophenotypic and functional features with those of UCB CD34+ cells. UCB AC133+ and CD34+ cell fractions were purified by magnetic cell sorting, analysed by flow cytometry, tested for their content in blast cell colony-forming units (CFU-Bl), erythroid and granulocyte-macrophage colony-forming units before and after expansion in the presence of various haemopoietic growth factor combinations. Median AC133+ cell yield was 62.3%, and median AC133+ population purity was 97.9%. AC133+ cells were found to contain significantly more CFU-Bl than CD34+ cells; furthermore, the replating efficiency, i.e. the number of CFU-Bl capable of generating secondary colonies, was higher in the former than in the latter cells. Both AC133+ and CD34+ cells displayed an increased ability to give rise to committed progenitors after 7-day expansion in liquid cultures. These data suggest that the AC133+ cell subset is a heterogeneous pool of immature and more differentiated cells that can be maintained and expanded in well-defined culture conditions. In comparison with CD34+ cells, UCB AC133+ cells appear to contain a higher number of early haemopoietic progenitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792285     DOI: 10.1046/j.1365-2141.2000.01949.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor.

Authors:  D Freund; J Oswald; S Feldmann; G Ehninger; D Corbeil; M Bornhäuser
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

Review 2.  Establishing humanized mice using stem cells: maximizing the potential.

Authors:  D Bernard; M Peakman; A C Hayday
Journal:  Clin Exp Immunol       Date:  2008-04-24       Impact factor: 4.330

3.  Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells.

Authors:  Tuija Kekarainen; Sirkka Mannelin; Jarmo Laine; Taina Jaatinen
Journal:  BMC Cell Biol       Date:  2006-08-01       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.